 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
May 09, 2012
Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fate of Medco's Personalized Medicine Programs Uncertain Under Express Scripts' Acquisition Plan
July 27, 2011 / Pharmacogenomics Reporter - FDA's Rx/Dx Draft Guidance Urges Simultaneous Development, but Addresses Alternative Scenarios
July 13, 2011 / Pharmacogenomics Reporter - CVS Caremark, Generation Health Unveil 13 Drugs for PGx Testing Program, But Not Warfarin
June 2, 2010 / Pharmacogenomics Reporter - Medco to Expand PGx Offerings to All Clients in July
May 26, 2010 / Pharmacogenomics Reporter - With Medco Around for Dx Shops Developing PGx Tests Independently, Who Needs Pharma?
April 14, 2010 / Pharmacogenomics Reporter